Plus Therapeutics | 8-K: Current report
Plus Therapeutics | 8-K: Current report
Plus Therapeutics | 8-K: Current report
Plus Therapeutics | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
Plus Therapeutics | 8-K: Plus Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights
Plus Therapeutics | S-1: General form for registration of securities under the Securities Act of 1933
Plus Therapeutics | 8-K: Current report
Plus Therapeutics | S-1: General form for registration of securities under the Securities Act of 1933
Plus Therapeutics | 8-K: Current report
Plus Therapeutics | 8-K: Plus Therapeutics Reports Third Quarter 2023 Financial Results and Business Highlights
Plus Therapeutics | 8-K: Plus Therapeutics Reports Second Quarter 2023 Financial Results and Business Highlights
Plus Therapeutics | S-1: General form for registration of securities under the Securities Act of 1933
Plus Therapeutics | 8-K: Current report
Plus Therapeutics | 8-K: Current report
Plus Therapeutics | 8-K: Current report
Plus Therapeutics | 8-K: Plus Therapeutics Reports First Quarter 2023 Financial Results and Business Highlights
Plus Therapeutics | 8-K: Current report
Plus Therapeutics | DEF 14A: Definitive proxy statements
Plus Therapeutics | 8-K: Current report
Plus Therapeutics | PRE 14A: Preliminary proxy statement not related to a contested matter or merger/acquisition
No Data